Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Glycated Fibrinogen: A New Index of Short-Term Diabetic Control

View through CrossRef
Fibrinogen is a plasma protein with a short half-life of four days and, therefore, glycated fibrinogen may be valuable as an index of short-term diabetic control. We have developed a simple, rapid method for determining glycated fibrinogen using affinity chromatography. The differences in the percentage of glycated fibrinogen between normal subjects, well-controlled diabetics and poorly-controlled diabetics were highly significant. There was a significant correlation between glycated fibrinogen and glycated haemoglobin for all these subjects. However, in selected subjects with rapidly improving diabetic control the difference between the fall over three days in glycated fibrinogen and glycated haemoglobin was highly significant. In subjects with deteriorating control over an average of four weeks there was a significant difference between the increase in glycated fibrinogen and glycated haemoglobin. We suggest that glycated fibrinogen may be a valuable adjunct to glucose measurements in the assessment of short-term diabetic control due to its rapid change following alterations in control.
Title: Glycated Fibrinogen: A New Index of Short-Term Diabetic Control
Description:
Fibrinogen is a plasma protein with a short half-life of four days and, therefore, glycated fibrinogen may be valuable as an index of short-term diabetic control.
We have developed a simple, rapid method for determining glycated fibrinogen using affinity chromatography.
The differences in the percentage of glycated fibrinogen between normal subjects, well-controlled diabetics and poorly-controlled diabetics were highly significant.
There was a significant correlation between glycated fibrinogen and glycated haemoglobin for all these subjects.
However, in selected subjects with rapidly improving diabetic control the difference between the fall over three days in glycated fibrinogen and glycated haemoglobin was highly significant.
In subjects with deteriorating control over an average of four weeks there was a significant difference between the increase in glycated fibrinogen and glycated haemoglobin.
We suggest that glycated fibrinogen may be a valuable adjunct to glucose measurements in the assessment of short-term diabetic control due to its rapid change following alterations in control.

Related Results

KADAR FIBRINOGEN SEBAGAI FAKTOR PROGNOSTIK PASIEN PERDARAHAN INTRASEREBRAL SPONTAN
KADAR FIBRINOGEN SEBAGAI FAKTOR PROGNOSTIK PASIEN PERDARAHAN INTRASEREBRAL SPONTAN
         FIBRINOGEN VALUE AS PROGNOSTIC FACTOR IN SPONTANEOUS INTRACEREBRAL HEMORRHAGEABSTRACTIntroduction: Spontaneous intracerebral haemorrhage (SIH) refers as spontaneous bleedi...
Discovery of free glycated amines and glycated urea as potential markers of diabetic nephropathy
Discovery of free glycated amines and glycated urea as potential markers of diabetic nephropathy
Abstract The role of protein glycation in the pathogenesis of diabetes is well established. Akin to proteins, free amino acids and other small-mo...
Kaolin thromboelastography as an index of diabetic foot severity: Preliminary results in summary
Kaolin thromboelastography as an index of diabetic foot severity: Preliminary results in summary
Background: This observational study compares the use of thromboelastography (TEG) in the diagnosis of Normal Foot (NP/C), Diabetic Foot (DF), Diabetic Foot with Ulcer (DFU), and U...
Fibrinogen interaction with complement C3: a potential therapeutic target to reduce thrombosis risk
Fibrinogen interaction with complement C3: a potential therapeutic target to reduce thrombosis risk
Complement C3 binds fibrinogen and compromises fibrin clot lysis thereby enhancing thrombosis risk. We investigated the role of fibrinogen-C3 interaction as a novel therapeutic tar...
Plasma Fibrinogen as a Diagnostic Marker in Sample Patients with Type 2 Diabetes
Plasma Fibrinogen as a Diagnostic Marker in Sample Patients with Type 2 Diabetes
Abstract Background Diabetes, a heterogeneous metabolic disorder characterized by hyperglycemia, poses a significant global heal...

Back to Top